Pascal Hammel

31.5k citations
365 papers · 15.8k · 5 hit papers · h-index 64

Impact in

  • Oncology top 0.05%
    • Pancreatic and Hepatic Oncology Research
    • Lung Cancer Research Studies
    • Cancer Genomics and Diagnostics

Papers in

    • Pancreatic and Hepatic Oncology Research 179
    • Lung Cancer Research Studies 22
    • Pancreatitis Pathology and Treatment 53
    • Cholangiocarcinoma and Gallbladder Cancer Studies 18

Pascal Hammel

347 papers receiving 15.5k citations

Pascal Hammel's Hit Papers

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib 2016 · 706 citations
7060+7+14Years since publication50010001.5k

Peers

Pascal Hammel
Comparison fields: 5 of 120
  • Oncology 10.0k
  • Cancer Research 2.1k
  • Epidemiology 4.3k
  • Neurology 1.6k
  • Surgery 3.8k
Replace Casper H.J. van Eijck with:
Casper H.J. van Eijck Netherlands
Juan W. Valle United Kingdom
Christopher L. Wolfgang United States
Volkan Adsay United States
Emilio Bajetta Italy
Rocio García‐Carbonero Spain
Emily K. Bergsland United States
Ross A. Abrams United States
Jakob R. Izbicki Germany
Barish H. Edil United States
Pascal Hammel relative to Casper H.J. van Eijck Netherlands Casper H.J. van Eijck's profile →
Citations per field
00.5×1.5×
Casper H.J. van Eijck · 1×
Citations per year

Countries citing papers authored by Pascal Hammel

Since Specialization
Citations

This map shows the geographic impact of Pascal Hammel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Hammel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Hammel more than expected).

Fields of papers citing papers by Pascal Hammel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Hammel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Hammel. The network helps show where Pascal Hammel may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal Hammel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal Hammel Line = papers co-authored together Pascal Hammel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 365 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Hit paper breakdown →
20111814
2
Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial
Hit paper breakdown →
2005760
3
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
Hit paper breakdown →
2016706
4
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
Hit paper breakdown →
2015510
5
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
Hit paper breakdown →
2008507
6 2007375
7 2000320
8 2001308
9 2000268
10 2001236
11 2018222
12 2000215
13 2008201
14 2008195
15 2010193
16 1995190
17 2008180
18 2014171
19 1995157
20 2000154

About Pascal Hammel

Pascal Hammel is a scholar working on Oncology, Surgery, Epidemiology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 365 papers that have together received 15.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (179 papers), Neuroendocrine Tumor Research Advances (71 papers), Cancer Genomics and Diagnostics (55 papers), Pancreatitis Pathology and Treatment (53 papers), Neuroblastoma Research and Treatments (25 papers), Lung Cancer Research Studies (22 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Renal cell carcinoma treatment (16 papers). The work is most often cited by research in Oncology (10.0k citations), Cancer Research (2.1k citations), Epidemiology (4.3k citations), Neurology (1.6k citations) and Surgery (3.8k citations). Pascal Hammel has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Philippe Ruszniewski, Alain Sauvanet, Anne Couvelard, Philippe Lévy, Dermot O’Toole, Christophe Louvet, Thierry André, P Bernadès, Olivia Hentic and Frédérique Maire. Their work appears in journals such as Journal of Clinical Oncology, Pancreatology, Gastroenterology, Annals of Oncology and Pancreas.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact